Clinical trial
Short Course Intermittent Regimens for the Treatment of HIV-Associated…
NCT00376012 · Tuberculosis Research Centre, India, Other · Unknown status
Key facts
| NCT number | NCT00376012 |
|---|---|
| Title | Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis |
| Official title | Randomized Clinical Trial to Assess the Efficacy of Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis |
| Lead sponsor | Tuberculosis Research Centre, India, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tuberculosis, Human Immunodeficiency Virus Infections |
| Intervention type | Drug |
| Interventions | Anti-TB drugs (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide) |
| Enrollment | 300 |
| Start date | Feb 1, 2001 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Sep 14, 2006 |
| Last update posted | Jun 11, 2008 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: